Article Type
Changed
Mon, 01/14/2019 - 10:58
Display Headline
Evidence or bias?

How do we use evidence? To objectively guide patient care or to support our biases?

At a recent conference on evidence-based medicine, we reviewed a meta-analysis that found inhaled beta-agonists ineffective for acute cough or bronchitis.1 During the discussion, some physicians thought the idea of using beta-agonists to treat acute cough was mainly a pharmaceutical advertising gimmick; one participant stated this article was the information needed to debunk that propaganda.

During another evidence-based medicine event, a critique of an article on spironolactone in heart failure2 revealed divergent opinions. The study in question reported significant mortality improvement when patients with New York Heart Association class III and IV heart failure were given spironolactone. Some felt the low cost and demonstration of clear benefit justified applying information from sicker patients to those with milder (class I and II) disease, while others argued this was an unjustified leap of faith.

How do values shape decisions?

These 2 discussions raise an important question: To what extent is our clinical application of evidence shaped by our values, biases, or expectations? Values shape decisions as to which research to pursue, which articles to read, and which patient-oriented outcomes are most important—both the search for evidence and the application of evidence are valuedirected endeavors.

Nevertheless, if the goal of evidence-based medicine is“the conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients,”3 then it is our duty to conscientiously present evidence so that our patients’ decisions may be truly reflective of their own values.

Asking the right clinical question

An important step in practicing evidence-based medicine is asking a “well-built” clinical question that is “directly relevant to the problem at hand” and facilitates “searching for a precise answer.”4 Thus, the application of evidence to a particular case depends on the precision of the clinical question, the precision of the evidencebased answer, and the degree to which the answer fits the question.

The meta-analysis of beta-agonists addressed the broad question of their use for cough in general but not the more precise question of their use in patients with cough and wheeze, though this subgroup was found to benefit in 2 individual studies.5,6 The study of spironolactone addressed a more precise question, but the issue in discussion was the applicability of the evidence more broadly beyond the initial scenario.

Matching evidence to patients

My point is not to challenge the findings of the 2 articles, but to highlight the role values and biases can play in the application of evidence. Whether the issue is using evidence from a broad set of studies (cough in general) to address a more specific clinical scenario (cough with wheeze), or applying information from sick patients (class III and IV heart failure) to less severely ill (class I and II heart failure) patients, biases and values can play a significant role in the application of evidence to patient care.

If solid evidence-based medicine was readily available to answer every possible clinical question, medical practice would be straightforward. But for now we are faced with a wide array of medical practices and patient problems and a relative paucity of evidence. When we cannot find the information that directly answers a particular clinical question, patient and clinician values become a factor. If evidence suggests abandoning a treatment, we must be sure that the evidence directly addresses the clinical scenario we might use that treatment for. If there is evidence supporting a new treatment, we must ask how much more evidence we need before broadening the use of that treatment to other, slightly different scenarios.

Whatever the clinical scenario, we must bear in mind that applying evidence-based medicine to patient care involves a complex interplay of evidence and values. To be “conscientious, explicit, and judicious” in our practice of evidence-based medicine, we must be precise in framing clinical questions, diligent in searching for precise answers, honest in understanding the role of our own values as we assess evidence, and faithful to our patients in translating evidence into information they can use to form decisions.

References

1. Smucny JJ, Flynn CA, Becker LA, Glazier RH. Are beta2agonists effective treatment for acute bronchitis or acute cough in patients without underlying pulmonary disease? A systematic review. J Fam Pract 2001;50:945-951.

2. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709-717.

3. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. BMJ 1996;312:71-72.

4. Richardson WC, Wilson MC, Nishikawa J, Hayward RS. The well-built clinical question: a key to evidence-based decisions. ACP J Club 1995;123:A12-13.

5. Hueston WJ. Albuterol delivered by metered-dose inhaler to treat acute bronchitis: a placebo-controlled double-blind study. J Fam Pract 1994;39:437-440.

6. Hueston WJ. A comparison of albuterol and erythromycin for the treatment of acute bronchitis. J Fam Pract 1991;33:476-480.

Article PDF
Author and Disclosure Information

William E. Cayley, Jr,, MD, MDiv
Eau Claire Family Medicine Residency, Eau Claire, Wisc
E-mail: [email protected]

Issue
The Journal of Family Practice - 52(5)
Publications
Page Number
380-381
Sections
Author and Disclosure Information

William E. Cayley, Jr,, MD, MDiv
Eau Claire Family Medicine Residency, Eau Claire, Wisc
E-mail: [email protected]

Author and Disclosure Information

William E. Cayley, Jr,, MD, MDiv
Eau Claire Family Medicine Residency, Eau Claire, Wisc
E-mail: [email protected]

Article PDF
Article PDF

How do we use evidence? To objectively guide patient care or to support our biases?

At a recent conference on evidence-based medicine, we reviewed a meta-analysis that found inhaled beta-agonists ineffective for acute cough or bronchitis.1 During the discussion, some physicians thought the idea of using beta-agonists to treat acute cough was mainly a pharmaceutical advertising gimmick; one participant stated this article was the information needed to debunk that propaganda.

During another evidence-based medicine event, a critique of an article on spironolactone in heart failure2 revealed divergent opinions. The study in question reported significant mortality improvement when patients with New York Heart Association class III and IV heart failure were given spironolactone. Some felt the low cost and demonstration of clear benefit justified applying information from sicker patients to those with milder (class I and II) disease, while others argued this was an unjustified leap of faith.

How do values shape decisions?

These 2 discussions raise an important question: To what extent is our clinical application of evidence shaped by our values, biases, or expectations? Values shape decisions as to which research to pursue, which articles to read, and which patient-oriented outcomes are most important—both the search for evidence and the application of evidence are valuedirected endeavors.

Nevertheless, if the goal of evidence-based medicine is“the conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients,”3 then it is our duty to conscientiously present evidence so that our patients’ decisions may be truly reflective of their own values.

Asking the right clinical question

An important step in practicing evidence-based medicine is asking a “well-built” clinical question that is “directly relevant to the problem at hand” and facilitates “searching for a precise answer.”4 Thus, the application of evidence to a particular case depends on the precision of the clinical question, the precision of the evidencebased answer, and the degree to which the answer fits the question.

The meta-analysis of beta-agonists addressed the broad question of their use for cough in general but not the more precise question of their use in patients with cough and wheeze, though this subgroup was found to benefit in 2 individual studies.5,6 The study of spironolactone addressed a more precise question, but the issue in discussion was the applicability of the evidence more broadly beyond the initial scenario.

Matching evidence to patients

My point is not to challenge the findings of the 2 articles, but to highlight the role values and biases can play in the application of evidence. Whether the issue is using evidence from a broad set of studies (cough in general) to address a more specific clinical scenario (cough with wheeze), or applying information from sick patients (class III and IV heart failure) to less severely ill (class I and II heart failure) patients, biases and values can play a significant role in the application of evidence to patient care.

If solid evidence-based medicine was readily available to answer every possible clinical question, medical practice would be straightforward. But for now we are faced with a wide array of medical practices and patient problems and a relative paucity of evidence. When we cannot find the information that directly answers a particular clinical question, patient and clinician values become a factor. If evidence suggests abandoning a treatment, we must be sure that the evidence directly addresses the clinical scenario we might use that treatment for. If there is evidence supporting a new treatment, we must ask how much more evidence we need before broadening the use of that treatment to other, slightly different scenarios.

Whatever the clinical scenario, we must bear in mind that applying evidence-based medicine to patient care involves a complex interplay of evidence and values. To be “conscientious, explicit, and judicious” in our practice of evidence-based medicine, we must be precise in framing clinical questions, diligent in searching for precise answers, honest in understanding the role of our own values as we assess evidence, and faithful to our patients in translating evidence into information they can use to form decisions.

How do we use evidence? To objectively guide patient care or to support our biases?

At a recent conference on evidence-based medicine, we reviewed a meta-analysis that found inhaled beta-agonists ineffective for acute cough or bronchitis.1 During the discussion, some physicians thought the idea of using beta-agonists to treat acute cough was mainly a pharmaceutical advertising gimmick; one participant stated this article was the information needed to debunk that propaganda.

During another evidence-based medicine event, a critique of an article on spironolactone in heart failure2 revealed divergent opinions. The study in question reported significant mortality improvement when patients with New York Heart Association class III and IV heart failure were given spironolactone. Some felt the low cost and demonstration of clear benefit justified applying information from sicker patients to those with milder (class I and II) disease, while others argued this was an unjustified leap of faith.

How do values shape decisions?

These 2 discussions raise an important question: To what extent is our clinical application of evidence shaped by our values, biases, or expectations? Values shape decisions as to which research to pursue, which articles to read, and which patient-oriented outcomes are most important—both the search for evidence and the application of evidence are valuedirected endeavors.

Nevertheless, if the goal of evidence-based medicine is“the conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients,”3 then it is our duty to conscientiously present evidence so that our patients’ decisions may be truly reflective of their own values.

Asking the right clinical question

An important step in practicing evidence-based medicine is asking a “well-built” clinical question that is “directly relevant to the problem at hand” and facilitates “searching for a precise answer.”4 Thus, the application of evidence to a particular case depends on the precision of the clinical question, the precision of the evidencebased answer, and the degree to which the answer fits the question.

The meta-analysis of beta-agonists addressed the broad question of their use for cough in general but not the more precise question of their use in patients with cough and wheeze, though this subgroup was found to benefit in 2 individual studies.5,6 The study of spironolactone addressed a more precise question, but the issue in discussion was the applicability of the evidence more broadly beyond the initial scenario.

Matching evidence to patients

My point is not to challenge the findings of the 2 articles, but to highlight the role values and biases can play in the application of evidence. Whether the issue is using evidence from a broad set of studies (cough in general) to address a more specific clinical scenario (cough with wheeze), or applying information from sick patients (class III and IV heart failure) to less severely ill (class I and II heart failure) patients, biases and values can play a significant role in the application of evidence to patient care.

If solid evidence-based medicine was readily available to answer every possible clinical question, medical practice would be straightforward. But for now we are faced with a wide array of medical practices and patient problems and a relative paucity of evidence. When we cannot find the information that directly answers a particular clinical question, patient and clinician values become a factor. If evidence suggests abandoning a treatment, we must be sure that the evidence directly addresses the clinical scenario we might use that treatment for. If there is evidence supporting a new treatment, we must ask how much more evidence we need before broadening the use of that treatment to other, slightly different scenarios.

Whatever the clinical scenario, we must bear in mind that applying evidence-based medicine to patient care involves a complex interplay of evidence and values. To be “conscientious, explicit, and judicious” in our practice of evidence-based medicine, we must be precise in framing clinical questions, diligent in searching for precise answers, honest in understanding the role of our own values as we assess evidence, and faithful to our patients in translating evidence into information they can use to form decisions.

References

1. Smucny JJ, Flynn CA, Becker LA, Glazier RH. Are beta2agonists effective treatment for acute bronchitis or acute cough in patients without underlying pulmonary disease? A systematic review. J Fam Pract 2001;50:945-951.

2. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709-717.

3. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. BMJ 1996;312:71-72.

4. Richardson WC, Wilson MC, Nishikawa J, Hayward RS. The well-built clinical question: a key to evidence-based decisions. ACP J Club 1995;123:A12-13.

5. Hueston WJ. Albuterol delivered by metered-dose inhaler to treat acute bronchitis: a placebo-controlled double-blind study. J Fam Pract 1994;39:437-440.

6. Hueston WJ. A comparison of albuterol and erythromycin for the treatment of acute bronchitis. J Fam Pract 1991;33:476-480.

References

1. Smucny JJ, Flynn CA, Becker LA, Glazier RH. Are beta2agonists effective treatment for acute bronchitis or acute cough in patients without underlying pulmonary disease? A systematic review. J Fam Pract 2001;50:945-951.

2. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709-717.

3. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. BMJ 1996;312:71-72.

4. Richardson WC, Wilson MC, Nishikawa J, Hayward RS. The well-built clinical question: a key to evidence-based decisions. ACP J Club 1995;123:A12-13.

5. Hueston WJ. Albuterol delivered by metered-dose inhaler to treat acute bronchitis: a placebo-controlled double-blind study. J Fam Pract 1994;39:437-440.

6. Hueston WJ. A comparison of albuterol and erythromycin for the treatment of acute bronchitis. J Fam Pract 1991;33:476-480.

Issue
The Journal of Family Practice - 52(5)
Issue
The Journal of Family Practice - 52(5)
Page Number
380-381
Page Number
380-381
Publications
Publications
Article Type
Display Headline
Evidence or bias?
Display Headline
Evidence or bias?
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media